<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26982784</article-id>
      <article-id pub-id-type="pmc">4782652</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164046</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Erosive lichen planus: a therapeutic challenge<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Romero</surname>
            <given-names>Williams</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Giesen</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navajas-Galimany</surname>
            <given-names>Lucas</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez</surname>
            <given-names>Sergio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Pontificia Universidad Cat&#xF3;lica de Chile -
Santiago, Chile.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Mailing address: Lucas Navajas Galimany, Av. Vicuna Mackenna 4686.
Santiago, Chile. E-mail: <email>lfnavaja@uc.cl</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>1</issue>
      <fpage>84</fpage>
      <lpage>86</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Erosive lichen planus is an uncommon variant of lichen planus. Chronic erosions
of the soles, accompanied by intense and disabling pain, are some of its most
characteristic manifestations. We present the case of a woman who developed oral
and plantar erosive lichen planus associated with lichen planus pigmentosus and
ungueal lichen planus that were diagnosed after several years. The patient
failed to respond to multiple therapies requiring longstanding medication but
remained refractory. Knowledge of the treatment options for erosive lichen
planus is insufficient. Further research is required to clarify their
effectiveness, ideally adopting an evidence-based methodology.</p>
      </abstract>
      <kwd-group>
        <kwd>Cyclosporine</kwd>
        <kwd>Lichen planus</kwd>
        <kwd>Methotrexate</kwd>
        <kwd>Steroids</kwd>
        <kwd>Tacrolimus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Erosive lichen planus (ELP) is a very uncommon variant of lichen planus with mucosal,
palm and/or plantar involvement. It usually presents with chronic erosion of the
soles, accompanied by intense, disabling pain and progressive loss of toenails.
Multiple treatment options have been proposed, but none of them has consistently
demonstrated remission of lesions. We present the case of a woman with longstanding
erosive plantar lesions, highlighting the difficulty in making an early diagnosis
and achieving clinical response.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A healthy, 75 year-old woman visited our outpatient clinic after 10 years of
progressive destruction of her toenails and emergence of painful lesions on both
heels, which later became erosive. Oral lesions appeared 5 years later and during
the preceding 6 months she had noted progressive appearance of pruritic lesions on
the groins and back. On physical examination, the patient presented with
well-defined extensive erosions on both heels; erosive plaques on the buccal mucosa;
hyperpigmented lichenoid papules on the groins and back; destruction of the ungueal
lamina and dorsal pterygium on her feet (<xref ref-type="fig" rid="f01">Figures
1</xref> and <xref ref-type="fig" rid="f02">2</xref>). Laboratory testing showed
no findings and serologic studies for HIV, HCV and HBV were negative. The
histopathological study revealed orthoqueratosis, epidermic atrophy, vacuolar
degeneration of basal keratinocytes, neutrophil exocytosis, Civatte bodies and dense
perivascular superficial infiltrate (<xref ref-type="fig" rid="f03">Figure
3</xref>). These findings, together with the clinical manifestations, confirmed the
diagnosis of oral and plantar erosive lichen planus associated with lichen planus
pigmentosus and ungueal lichen planus. We started treatment with systemic
corticosteroids (prednisone 1 mg/kg), topical treatment on both heels using
clobetasol 0.05% interchanged with tacrolimus 0.1% twice daily, as well as oral
topical treatment with betamethasone and tetracycline. Due to a complete lack of
response, cyclosporine was initiated at a dosage of 50 mg three times a day. The
patient's blood pressure increased without improvement in skin lesions, so
cyclosporine was discontinued and methotrexate was started at a dosage of 15
mg/week. Thus far, the patient has undergone follow-up for approximately five
months, taking up to 20 mg/week of methotrexate and only partial regression has been
observed. We recently discontinued methotrexate and treatment using thalidomide was
proposed but the patient decided to stop all treatments and keep only plastic
dressings with moisturizers on her feet to walk and avoid more damage.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Brilliant erythematous plaques with extensive superficial erosions on
both heels</p></caption><graphic xlink:href="abd-91-01-0084-g01"/></fig>
</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Destruction of ungueal lamina, with anonychia and dorsal pterygium on
both feet</p></caption><graphic xlink:href="abd-91-01-0084-g02"/></fig>
</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Microphotograph showing denuded skin with lymphocytic lichenoid
superficial infiltrates and fibrosis. HE, 100x</p></caption><graphic xlink:href="abd-91-01-0084-g03"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>ELP is a very uncommon variant of lichen planus.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> It is characterized by painful erosions of torpid evolution,
mainly localized in the plants, palms, scalp, oral and genital mucosa, as well as
typical lichen planus lesions in the nails, mucous membranes and skin.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> The natural course of this disorder
usually begins with erythematous plaques and blisters on the feet, which develop
into painful and disabling erosions, predominantly on the heels. Progressive toenail
destruction and dorsal pterygium, as well as painful erosions on the scalp, oral and
genital mucosa, are characteristic as the disease develops.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> It is frequently accompanied by a
significant functional impairment. Malignant transformation to squamous cell
carcinoma has been described as one of its main and latest complications.</p>
      <p>The etiology of lichen planus remains uncertain. The role of immune cellular
response, especially of T-cell lymphocytes and macrophages, has proven to be the
mainstay of its pathogenesis.<sup><xref rid="r4" ref-type="bibr">4</xref></sup>
T-cells may be responsible for keratinocyte apoptosis and intensifying inflammatory
response.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Among biopsies
from patients with ELP, TNF-a was over-expressed in the cytoplasm of the basal
epithelial keratinocytes.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup></p>
      <p>Owing to its chronic and refractory course, multiple treatment options have been
proposed, with variable results: systemic, local and intralesional glucocorticoids,
retinoids, cyclosporine, azathioprine, phototherapy, dapsone, thalidomide,
tacrolimus, among others. Although treatment is still controversial, topical
corticosteroids and topical calcineurin inhibitors are considered treatments of
choice for localized ELP forms. Both were tested in this case and none led to
clinical improvement. A systematic review published in 2012 intended to assess the
evidence supporting systemic therapies for ELP.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> A total of 420 ELP cases were identified. Systemic
corticosteroid treatment was the most commonly used (27% of all cases) and the
second most effective in reducing lesion count and symptoms. Among systemic
retinoids, acitre-tin exhibited the poorest performance, whereas both etretinate and
isotretinoin entailed significant pain relief and healing of erosions. Other common
treatments were immunosuppressant drugs, which were used in 8.87% of cases.
Azathioprine appeared to be the most effective, with complete resolution observed in
75% of cases and no recurrence reported up to 9 months after discontinuation.
Thalidomide yielded complete resolution of lesions in 50% of cases. Cyclosporine
produced near-complete resolution during therapy but presented a high recurrence
rate once treatment was discontinued. Importantly, this report lacks randomized
controlled trials; it is based mainly on expert opinions and case reports with very
low-quality evidence. Moreover, only a few studies describe treatment options for
the plantar variant, making results even more difficult to analyze. Extracorporeal
phototherapy has proven to be effective in T-cell mediated diseases and has been
successfully tested in recalcitrant forms of ELP.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> Low molecular weight heparin at low doses also demonstrated
good response, acting as an inhibitor of the hypersensitivity reaction
involved.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Another
treatment alternative is surgery, alone or together with cy-closporine, which has
been effective in patients with chronic, stable and localized lesions.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> In this case, our patient did not
respond to corticosteroids, cyclosporine nor methotrexate; she decided to stop all
treatments and keep only plastic dressings with moisturizers on her feet.</p>
      <p>In conclusion, this is an uncommon, chronic disorder, with a refractory course. We
stress the difficulty of establishing an early diagnosis and thus the importance of
high suspicion aroused by any erosive lesion of torpid evolution and characteristic
localization. Treatment is still controversial, while topical corticosteroids and
topical calcineurin inhibitors are the treatments of choice for localized forms.
Short pulses of systemic glucocorticoids, phototherapy, and systemic
immunosuppressors are available for generalized cases. Further research is required
to clarify their effectiveness, ideally drawing on an evidence-based methodology.
Meanwhile, prescriptions should be individualized according to comorbidities,
previous treatments, drug side effects and clinical experience. Long-term monitoring
of all patients is also very important, allowing early detection of a malignant
tumor.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Pontifical Catholic University of Chile - Santiago,
Chile.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rebora</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Erosive Lichen planus: what is this?</article-title>
          <source>Dermatology</source>
          <year>2002</year>
          <volume>205</volume>
          <fpage>226</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">12399667</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cram</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Kierland</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Winkelmann</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Ulcerative lichen planus of the feet</article-title>
          <source>Arch Dermatol</source>
          <year>1966</year>
          <volume>93</volume>
          <fpage>692</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="pmid">5932156</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garc&#xED;a Perez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez Pichardo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bueno Montes</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Liquen plano erosivo plantar con onicoatrofia</article-title>
          <source>Med Cutan Ibero Lat Am</source>
          <year>1982</year>
          <volume>10</volume>
          <fpage>89</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">6759806</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jim&#xE9;nez-S&#xE1;nchez</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Ferr&#xE1;ndiz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Moreno-Ram&#xED;rez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vallejo-Ben&#xED;tez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Camacho-Mart&#xED;nez</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Liquen plano erosivo plantar</article-title>
          <source>Actas Dermosifiliogr</source>
          <year>2012</year>
          <volume>103</volume>
          <fpage>448</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="pmid">22265010</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sklavounou-Andrikopoulou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chrysomali</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Iakovou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garinis</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Karameris</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Elevated serum levels of the apoptosis related molecules
TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus</article-title>
          <source>J Oral Pathol Med</source>
          <year>2004</year>
          <volume>33</volume>
          <fpage>386</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="pmid">15250829</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XY</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of nuclear factor-kappa B correlates with tumor
necrosis factor-alpha in oral lichen planus: a clinicopathologic study in
atrophic-erosive and reticular form</article-title>
          <source>J Oral Pathol Med</source>
          <year>2009</year>
          <volume>38</volume>
          <fpage>559</fpage>
          <lpage>564</lpage>
          <pub-id pub-id-type="pmid">19453840</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Kirby</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Immunologic aspects of dermal and oral lichen planus: a
review</article-title>
          <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
          <year>1997</year>
          <volume>83</volume>
          <fpage>358</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="pmid">9084200</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kou Ho</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hantash</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of current systemic treatment options for
erosive lichen planus</article-title>
          <source>Expert Rev Dermatol</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>269</fpage>
          <lpage>282</lpage>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elewa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Altenburg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zouboulis</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Recalcitrant severe erosive cutaneous lichen planus treat-ed with
extracorporeal photopheresis monotherapy</article-title>
          <source>Br J Dermatol</source>
          <year>2011</year>
          <volume>165</volume>
          <fpage>441</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">21495999</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patrone</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stinco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>La Pia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Frattasio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Francesco</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Surgery and cyclosporine A in the treatment of erosive lichen
planus of the feet</article-title>
          <source>Eur J Dermatol</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>243</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">9649671</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
